ritalin tablet 10 mg
novartis (singapore) pte ltd - methylphenidate hcl - tablet - 10 mg - methylphenidate hcl 10 mg
rayglo s & v pills
biscodyl 5mg
ritalin
novartis new zealand ltd - methylphenidate hydrochloride 10mg; - tablet - 10 mg - active: methylphenidate hydrochloride 10mg excipient: calcium phosphate gelatin lactose monohydrate magnesium stearate purified talc wheat starch - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.
ritalin la
novartis new zealand ltd - methylphenidate hydrochloride 10mg; - modified release capsule - 10 mg - active: methylphenidate hydrochloride 10mg excipient: ammonio methacrylate copolymer gelatin macrogol 6000 methacrylic acid copolymer purified talc sugar spheres tekprint tan sw-8010 titanium dioxide triethyl citrate - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.
ritalin la
novartis new zealand ltd - methylphenidate hydrochloride 20mg; - modified release capsule - 20 mg - active: methylphenidate hydrochloride 20mg excipient: ammonio methacrylate copolymer gelatin methacrylic acid copolymer type a-methacrylate acid-methacrylate copolymer 1:1, dry powder macrogol 6000 purified talc sugar spheres titanium dioxide triethyl citrate - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.
ritalin la
novartis new zealand ltd - methylphenidate hydrochloride 30mg; - modified release capsule - 30 mg - active: methylphenidate hydrochloride 30mg excipient: ammonio methacrylate copolymer gelatin methacrylic acid copolymer type a/methacrylic acid methacrylate copolymer 1:1, dry powder iron oxide yellow macrogol 6000 purified talc sugar spheres titanium dioxide triethyl citrate - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.
ritalin la
novartis new zealand ltd - methylphenidate hydrochloride 40mg; - modified release capsule - 40 mg - active: methylphenidate hydrochloride 40mg excipient: ammonio methacrylate copolymer gelatin methacrylic acid copolymer type a -/methacryllic acid-methacrylate coplymer 1:1 dry powder iron oxide black iron oxide red iron oxide yellow macrogol 6000 purified talc sugar spheres titanium dioxide triethyl citrate - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.
ritalin sr
novartis new zealand ltd - methylphenidate hydrochloride 20mg; ; - modified release tablet - 20 mg - active: methylphenidate hydrochloride 20mg excipient: carbon dioxide carnauba wax cetostearyl alcohol hypromellose ink lactose monohydrate magnesium stearate methylated spirits polyethylene glycol hydrogenated castor oil purified talc purified water titanium dioxide - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.
rubifen
aft pharmaceuticals ltd - methylphenidate hydrochloride 10mg; - tablet - 10 mg - active: methylphenidate hydrochloride 10mg excipient: calcium hydrogen phosphate dihydrate magnesium stearate maize starch microcrystalline cellulose
rubifen
aft pharmaceuticals ltd - methylphenidate hydrochloride 20mg; - tablet - 20 mg - active: methylphenidate hydrochloride 20mg excipient: calcium hydrogen phosphate dihydrate magnesium stearate maize starch microcrystalline cellulose